首页|期刊导航|中国比较医学杂志|基于动物实验系统评价真武汤治疗糖尿病肾脏病的效果及作用机制

基于动物实验系统评价真武汤治疗糖尿病肾脏病的效果及作用机制OA

Effect and mechanism of Zhenwu Tang in diabetic kidney disease treatment based on animal experiments

中文摘要英文摘要

目的 系统评价真武汤治疗糖尿病肾脏病(DKD)动物模型的疗效及作用机制.方法 检索中英文数据库(包括PubMed、Embase、Cochrane Library、Web of Science、CNKI、万方数据库、中国生物医学文献服务系统和维普资讯),检索时间为建库至2025年6月,纳入以真武汤干预DKD动物模型的实验研究,采用SYRCLE量表进行质量评价,用GRADE-CERQual框架评定证据质量,并应用RevMan 5.4软件进行统计分析.结果 共纳入13项研究,涉及db/db小鼠和SD大鼠模型,主要造模方式为链脲佐菌素(STZ)注射或联合高糖高脂饮食,以及"生大黄水煎液+氢化可的松"的脾肾阳虚证造模.结果显示,相比于模型组,真武汤干预能有效降低DKD动物肌酐、尿素氮、血糖、24 h尿蛋白等指标;并减轻肾小球硬化、肾小管损伤及纤维化.但应指出,有部分研究未观察到真武汤对模型空腹血糖的显著改善作用.机制研究表明,真武汤肾脏保护作用涉及抑制NF-κB炎症通路与激活Nrf2抗氧化通路为核心、二者通过调节活性氧水平形成交互网络的多靶点机制,并进一步介导足细胞保护(如上调nephrin)及抗纤维化等效应.证据质量评价显示,生化指标、尿蛋白及组织病理学证据质量"高",炎症与氧化应激为"中",足细胞蛋白为"低".结论 真武汤可通过"抗炎-抗氧化"交互为核心的多靶点网络对DKD动物模型发挥肾脏保护作用,且该作用具有一定剂量、时间效应.然而,未来仍需更多方法学严谨、高质量的基础研究加以验证,并深入探索其最佳剂量窗口和作用机制.

Objective This study systematically evaluated the efficacy and mechanism of action of Zhenwu Tang in treating diabetic kidney disease(DKD)using animal models.Methods Chinese and English databases(PubMed,Embase,Cochrane Library,Web of Science,CNKI,Wanfang Database,Chinese Biomedical Literature Service System,and VIP Information)were searched from inception until June 2025.Experimental studies investigating Zhenwu Tang intervention in DKD animal models were included.The systematic review centre for laboratory animal experimentation tool was used to assess the quality,the GRADE-CERQual framework was applied to evaluate the certainty of evidence,and RevMan 5.4 was used for statistical analysis.Results Thirteen studies were included,involving db/db mice and SD rat models.The primary modeling methods induded streptozotocin(STZ)injection or STZ combined with a high sugar and fat diet.Spleen-kidney yang deficiency syndrome was induced using a decoction of raw Rheum palmatum combined with hydrocortisone.Compared with model groups,Zhenwu Tang intervention significantly reduced key indicators,including serum creatinine,blood urea nitrogen,fasting plasma glucose,and 24-hour urinary protein excretion in DKD animals,though some studies did not observe a significant improvement in fasting plasma glucose with Zhenwu Tang intervention;it also ameliorated glomerulosclerosis,tubular injury,and renal fibrosis.The renal protective effects of Zhenwu Tang involve a multi-target network centered on crosstalk between suppressed nuclear factor-KB-mediated inflammation and activation of Nrf2-driven anti-oxidation,interconnected through reactive oxygen species modulation,leading to downstream effects such as key podocyte protection(upregulation of the key podocyte protein nephrin)and anti-fibrosis.The certainty of evidence was graded as"High"for biochemical parameters,urinary protein,and histopathological findings;"Moderate"for inflammation and oxidative stress markers;and"Low"for podocyte protein expression.Conclusions Zhenwu Tang exerts a renal protective effect in DKD animal models through a multi-target network centered on"anti-inflammatory-antioxidant"crosstalk,which is dose-and time-dependent.Future more rigorous and high-quality basic studies are needed to verify these findings and further explore the optimal dose window and mechanism of action.

林铭钐;冯文娟;翁舒珅;杨朝阳

福建中医药大学,福州 350122||福建中医药大学附属第三人民医院,福州 350122福建中医药大学,福州 350122福建中医药大学,福州 350122福建中医药大学,福州 350122

医药卫生

中医学真武汤糖尿病肾脏病动物模型系统评价

traditional Chinese medicineZhenwu Tangdiabetic kidney diseaseanimal modelsystematic review

《中国比较医学杂志》 2026 (8)

31-49,19

国家重点研发计划(2023YFC3503000)中医药创新团队及人才支持计划项目(ZYYCXTD-C-202408).

10.3969/j.issn.1671-7856.2026.08.004

评论